135 related articles for article (PubMed ID: 27188586)
1. Bosentan reverses the hypoxia-induced downregulation of the bone morphogenetic protein signaling in pulmonary artery smooth muscle cells.
Maruyama H; Dewachter C; Sakai S; Belhaj A; Rondelet B; Remmelink M; Vachiéry JL; Naeije R; Dewachter L
Life Sci; 2016 Aug; 159():111-115. PubMed ID: 27188586
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension.
Takahashi H; Goto N; Kojima Y; Tsuda Y; Morio Y; Muramatsu M; Fukuchi Y
Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L450-8. PubMed ID: 16361357
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor antagonists attenuate the inflammatory response of human pulmonary vascular smooth muscle cells to bacterial endotoxin.
Knobloch J; Feldmann M; Wahl C; Jungck D; Behr J; Stoelben E; Koch A
J Pharmacol Exp Ther; 2013 Aug; 346(2):290-9. PubMed ID: 23720457
[TBL] [Abstract][Full Text] [Related]
6. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
7. Reduction of reactive oxygen species prevents hypoxia-induced CREB depletion in pulmonary artery smooth muscle cells.
Klemm DJ; Majka SM; Crossno JT; Psilas JC; Reusch JE; Garat CV
J Cardiovasc Pharmacol; 2011 Aug; 58(2):181-91. PubMed ID: 21562428
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in the proliferative response of bovine pulmonary artery smooth muscle cells to mitogens and hypoxia: importance of protein kinase C.
Dempsey EC; Frid MG; Aldashev AA; Das M; Stenmark KR
Can J Physiol Pharmacol; 1997 Jul; 75(7):936-44. PubMed ID: 9315363
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 induces pulmonary but not aortic smooth muscle cell migration by activating ERK1/2 MAP kinase.
Meoli DF; White RJ
Can J Physiol Pharmacol; 2010 Aug; 88(8):830-9. PubMed ID: 20725141
[TBL] [Abstract][Full Text] [Related]
10. Id proteins are critical downstream effectors of BMP signaling in human pulmonary arterial smooth muscle cells.
Yang J; Li X; Li Y; Southwood M; Ye L; Long L; Al-Lamki RS; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2013 Aug; 305(4):L312-21. PubMed ID: 23771884
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1.
Wu X; Chang MS; Mitsialis SA; Kourembanas S
Circ Res; 2006 Aug; 99(3):240-7. PubMed ID: 16840720
[TBL] [Abstract][Full Text] [Related]
12. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.
Eddahibi S; Fabre V; Boni C; Martres MP; Raffestin B; Hamon M; Adnot S
Circ Res; 1999 Feb; 84(3):329-36. PubMed ID: 10024307
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent.
Biasin V; Chwalek K; Wilhelm J; Best J; Marsh LM; Ghanim B; Klepetko W; Fink L; Schermuly RT; Weissmann N; Olschewski A; Kwapiszewska G
Int J Biochem Cell Biol; 2014 Sep; 54():137-48. PubMed ID: 25016214
[TBL] [Abstract][Full Text] [Related]
14. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells.
Sheares KK; Jeffery TK; Long L; Yang X; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L919-27. PubMed ID: 15220111
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of phosphatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells.
Garat CV; Crossno JT; Sullivan TM; Reusch JE; Klemm DJ
J Cardiovasc Pharmacol; 2013 Dec; 62(6):539-48. PubMed ID: 24084215
[TBL] [Abstract][Full Text] [Related]
17. Antagonists to endothelin receptor type B promote apoptosis in human pulmonary arterial smooth muscle cells.
Sakai S; Maruyama H; Kimura T; Tajiri K; Honda J; Homma S; Aonuma K; Miyauchi T
Life Sci; 2016 Aug; 159():116-120. PubMed ID: 27021787
[TBL] [Abstract][Full Text] [Related]
18. Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation.
Maruyama H; Sakai S; Dewachter L; Dewachter C; Rondelet B; Naeije R; Ieda M
Life Sci; 2023 Feb; 315():121372. PubMed ID: 36608870
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension.
Frank DB; Abtahi A; Yamaguchi DJ; Manning S; Shyr Y; Pozzi A; Baldwin HS; Johnson JE; de Caestecker MP
Circ Res; 2005 Sep; 97(5):496-504. PubMed ID: 16100039
[TBL] [Abstract][Full Text] [Related]
20. Dorsomorphin homologue 1, a highly selective small-molecule bone morphogenetic protein inhibitor, suppresses medial artery calcification.
Lin T; Wang XL; Zettervall SL; Cai Y; Guzman RJ
J Vasc Surg; 2017 Aug; 66(2):586-593. PubMed ID: 27374065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
